Clinical Trial Update: Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for a combination of calaspargase pegol-mnkl and cobimetinib in locally advanced or metastatic pancreatic cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Calaspargase pegol-mnkl (calaspargase pegol-mnkl)
• Cotellic (cobimetinib)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING